Millions of Americans are taking GLP-1 agonist medications like Ozempic, Wegovy, and Zepbound to lose weight, treat type 2 diabetes, and manage other chronic health conditions. And while these drugs are generally really effective, they can also bring on some not-so-great side effects, including a big drop in muscle mass for some people. Losing muscle
2 min read Ready to get into the best shape of your life? Get free weekly workouts and no-nonsense training insights delivered straight to your inbox. Sign up here and let the gains begin. THE GOAL WAS always to connect. It was 2019 and, as I do regularly for my job, I was talking with
4 min read EVERY SPORT HAS performance benchmarks. From breaking the 5-minute mile barrier as a runner to speeding through 40 kilometers in less than an hour as a cyclist to completing more than 700 meters in 12 minutes as a swimmer, using these numbers for your goals can take your everyday training to the
3D rendering of the new coronavirus, Covid-19. A man tells of his Covid-19 journey, which required a great deal of mental strength.Ramohemi Motshegoa describes his experience of excruciating pain on the 8th day of his journey.Motshegoa fought the virus in isolation at home with the support of his family. A Covid-19 survivor who has shared his…
Share on PinterestA new study suggests that grip strength may indicate type 2 diabetes risk. Early stage type 2 diabetes may not produce obvious symptoms, making detection difficult and often leading to cardiovascular issues. It is known, however, that the onset of type 2 diabetes may reveal itself through muscular weakness, which a reduction in…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.